Cancer chemotherapeutic drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells HCT116 Cells HT29 Cells Cell Line MCF-7 Cells KB Cells K562 Cells HL-60 Cells Mitochondria HeLa Cells Cells, Cultured Hep G2 Cells Spheroids, Cellular

Organisms6

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Adenoviridae Oncolytic Viruses

Diseases46

Neoplasms Breast Neoplasms Lung Neoplasms Colonic Neoplasms Ovarian Neoplasms Prostatic Neoplasms Neoplasms, Experimental Pancreatic Neoplasms Neoplasm Metastasis Stomach Neoplasms Melanoma, Experimental Neoplasm Invasiveness Adenocarcinoma Liver Neoplasms Melanoma Carcinoma Leukemia P388 Carcinoma, Squamous Cell Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Mammary Neoplasms, Experimental Neovascularization, Pathologic Urinary Bladder Neoplasms Brain Neoplasms Carcinoma, Hepatocellular Cell Transformation, Neoplastic Sarcoma 180 Bone Neoplasms Fibrosarcoma Leukemia L1210 Neuroblastoma Disease Progression Uterine Cervical Neoplasms Disease Models, Animal Skin Neoplasms Genetic Predisposition to Disease Neoplasm Recurrence, Local Glioblastoma Head and Neck Neoplasms Leukemia Lymphoma Osteosarcoma Rectal Neoplasms Glioma Carcinoma, Small Cell Esophageal Neoplasms

Chemicals and Drugs101

Hycanthone Tilorone Antineoplastic Agents Uracil Mustard Nitrogen Mustard Compounds Doxorubicin Cisplatin Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Paclitaxel Fluorouracil Etoposide P-Glycoprotein Antimetabolites, Antineoplastic Antineoplastic Agents, Alkylating Tumor Suppressor Protein p53 Neoplasm Proteins Cancer Vaccines Proto-Oncogene Proteins c-bcl-2 RNA, Small Interfering Camptothecin Deoxycytidine Caspases RNA, Messenger Vinblastine Daunorubicin Apoptosis Regulatory Proteins Cyclophosphamide Caspase 3 Antibodies, Monoclonal Taxoids Mitomycin Vincristine DNA, Neoplasm Enzyme Inhibitors TNF-Related Apoptosis-Inducing Ligand Organoplatinum Compounds Drug Carriers bcl-X Protein Multidrug Resistance-Associated Proteins Inhibitor of Apoptosis Proteins Prodrugs Proto-Oncogene Proteins c-akt Mitoxantrone Proto-Oncogene Proteins Antigens, Neoplasm Methotrexate Protein Kinase Inhibitors Bleomycin bcl-2-Associated X Protein Tumor Markers, Biological Receptors, TNF-Related Apoptosis-Inducing Ligand Dacarbazine ATP-Binding Cassette Transporters DNA-Binding Proteins Receptor, erbB-2 Carmustine Quinazolines Teniposide Receptor, Epidermal Growth Factor Fenretinide Radiation-Sensitizing Agents Pyrazines Poly(ADP-ribose) Polymerases Carboplatin Tumor Suppressor Proteins Protein-Serine-Threonine Kinases Nuclear Proteins Plant Extracts Boronic Acids Membrane Glycoproteins Angiogenesis Inhibitors Melphalan Bridged Compounds Antigens, CD95 Receptors, Estrogen Nanoconjugates Recombinant Proteins Cytarabine Piperazines Transcription Factors Organoselenium Compounds Topoisomerase II Inhibitors NF-kappa B Imidazoles Anticarcinogenic Agents Caspase 8 Dactinomycin Tamoxifen DNA Cell Cycle Proteins Sulfonamides Tumor Necrosis Factor-alpha Chlorambucil Caspase 9 Cyclin-Dependent Kinase Inhibitor p21 TOR Serine-Threonine Kinases Histone Deacetylase Inhibitors Carrier Proteins Antibodies, Monoclonal, Humanized Pyrimidines

Analytical, Diagnostic and Therapeutic Techniques and Equipment47

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Neoplasm Transplantation Antineoplastic Combined Chemotherapy Protocols Neoplasms, Experimental Early Detection of Cancer Drug Delivery Systems Inhibitory Concentration 50 Blotting, Western Transplantation, Heterologous Combined Modality Therapy Transfection Flow Cytometry Tumor Burden Melanoma, Experimental Reverse Transcriptase Polymerase Chain Reaction Immunotherapy Drug Carriers Mammary Neoplasms, Experimental Genetic Therapy Drug Evaluation, Preclinical Gene Expression Profiling Prognosis Survival Analysis Models, Biological Drug Administration Schedule Survival Rate Tumor Stem Cell Assay Treatment Outcome Clinical Trials as Topic Immunohistochemistry Disease Models, Animal Gene Knockdown Techniques Electrochemotherapy Neoplasm Staging Oligonucleotide Array Sequence Analysis Retrospective Studies Nanoconjugates Follow-Up Studies Disease-Free Survival Immunoblotting Molecular Targeted Therapy Risk Chemotherapy, Adjuvant Prospective Studies Immunotherapy, Adoptive Registries

Phenomena and Processes41

Apoptosis Cell Survival Dose-Response Relationship, Drug Drug Resistance, Neoplasm DNA Damage Drug Synergism Drug Resistance, Multiple Cell Proliferation Gene Expression Regulation, Neoplastic Cell Cycle Inhibitory Concentration 50 Cell Division Transfection Signal Transduction Down-Regulation Drug Resistance Cell Death Cell Growth Processes Up-Regulation RNA Interference Mutation Time Factors Phosphorylation Enzyme Activation Gene Silencing Gene Expression Cell Movement DNA Repair Genetic Vectors DNA Fragmentation Promoter Regions, Genetic Base Sequence Genes, p53 Genetic Predisposition to Disease Protein Binding Risk Phenotype Tissue Distribution Transcription, Genetic Radiation Tolerance Genes, MDR

Disciplines and Occupations2

Nanomedicine Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture3

Nanomedicine Nanoparticles Nanoconjugates

Information Science4

Survival Rate Molecular Sequence Data Base Sequence Registries

Named Groups1

Health Care11

Survival Analysis Survival Rate Treatment Outcome Clinical Trials as Topic Retrospective Studies Follow-Up Studies Disease-Free Survival National Cancer Institute (U.S.)Risk Prospective Studies Registries

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Hycanthone Tilorone Antineoplastic Agents Uracil Mustard Nitrogen Mustard Compounds Doxorubicin Cell Line, Tumor Neoplasms Apoptosis Cisplatin Antineoplastic Agents, Phytogenic Tumor Cells, Cultured Cell Survival Dose-Response Relationship, Drug Breast Neoplasms Drug Resistance, Neoplasm Drug Screening Assays, Antitumor DNA Damage Xenograft Model Antitumor Assays Antibiotics, Antineoplastic Mice, Nude Drug Synergism Paclitaxel Neoplasm Transplantation Lung Neoplasms Drug Resistance, Multiple Colonic Neoplasms Antineoplastic Combined Chemotherapy Protocols Fluorouracil Cell Proliferation Gene Expression Regulation, Neoplastic Ovarian Neoplasms Etoposide P-Glycoprotein Prostatic Neoplasms Antimetabolites, Antineoplastic Neoplasms, Experimental Antineoplastic Agents, Alkylating Tumor Suppressor Protein p53 Early Detection of Cancer Neoplasm Proteins Cell Cycle Drug Delivery Systems Mice, Inbred BALB C Mice, SCID Pancreatic Neoplasms Cancer Vaccines Proto-Oncogene Proteins c-bcl-2 Inhibitory Concentration 50 RNA, Small Interfering Blotting, Western Transplantation, Heterologous Neoplasm Metastasis Camptothecin Deoxycytidine Cell Division Stomach Neoplasms Caspases Combined Modality Therapy Transfection Flow Cytometry Tumor Burden Melanoma, Experimental RNA, Messenger Reverse Transcriptase Polymerase Chain Reaction Vinblastine Signal Transduction Daunorubicin Neoplasm Invasiveness Apoptosis Regulatory Proteins Down-Regulation Adenocarcinoma Liver Neoplasms Cyclophosphamide Immunotherapy Melanoma Neoplastic Stem Cells Caspase 3 Antibodies, Monoclonal Drug Resistance Carcinoma Taxoids Mitomycin Vincristine DNA, Neoplasm Cell Death Enzyme Inhibitors Leukemia P388 Cell Growth Processes Up-Regulation Carcinoma, Squamous Cell TNF-Related Apoptosis-Inducing Ligand Mice, Inbred C57BL Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung RNA Interference HCT116 Cells Mutation Time Factors Organoplatinum Compounds

No FAQ available that match "cancer chemotherapeutic drug screening assays antitumor"